ArticleClinical Medicine Insights. Oncology2022

The Tri-iodothyronine (T3) Level Is a Prognostic Factor for Patients With Advanced NSCLC: Receiving Immune Checkpoint Inhibitors and Is Associated With Liver Metastasis.

Yoonjoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.